Bain, S., Leiter, L. A., Bhatt, D. L., Buse, J. B., Mazer, C. D., Pratley, R. E., . . . Verma, S. (2020). The effect of glucagon‐like peptide‐1 receptor agonists liraglutide and semaglutide on cardiovascular and renal outcomes across baseline blood pressure categories: Analysis of the LEADER and SUSTAIN 6 trials. Diabetes, Obesity and Metabolism. doi:10.1111/dom.14079
Chicago Style CitationBain, Steve, et al. "The Effect of Glucagon‐like Peptide‐1 Receptor Agonists Liraglutide and Semaglutide On Cardiovascular and Renal Outcomes Across Baseline Blood Pressure Categories: Analysis of the LEADER and SUSTAIN 6 Trials." Diabetes, Obesity and Metabolism 2020.
MLA CitationBain, Steve, et al. "The Effect of Glucagon‐like Peptide‐1 Receptor Agonists Liraglutide and Semaglutide On Cardiovascular and Renal Outcomes Across Baseline Blood Pressure Categories: Analysis of the LEADER and SUSTAIN 6 Trials." Diabetes, Obesity and Metabolism 2020.